Remel, Inc recalls Yeastone Broth
- Published
- 11 Nov 2026
- Units affected
- 33 US, 54 OUS
- Agency
- FDA
- Country
- United States
The hazard
Affected lot did not meet specifications. Product may report false susceptibility to antifungal agents, specifically within the Azole family.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.
- Check the model and lot or serial number on the device label.
- Speak to your doctor or the clinic that supplied the device before stopping use.
Product details
Yeastone Broth, 11ML, 10/BOX, used in antibiotic susceptibility testing of mycological clinical specimens
- Brand / company
- Remel, Inc
- Codes / lots
- YY3462 lot 440400 UDI-DI 848838018817
- Distribution
- Worldwide - US Nationwide distribution in the states of MA and CA. The countries of India, Saudi Arabia, UK.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 11 Nov 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.